The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
FGF 23 regulates renal sodium handling and blood pressure
Open accessAbstract
Fibroblast growth factor‐23 ( FGF 23) is a bone‐derived hormone regulating renal phosphate reabsorption and vitamin D synthesis in renal proximal tubules. Here, we show that FGF 23 directly regulates the membrane abundance of the Na + :Cl − co‐transporter NCC in distal renal tubules by a signaling mechanism involving the FGF receptor/αKlotho complex, extracellular signal‐regulated kinase 1/2 ( ERK 1/2), serum/glucocorticoid‐regulated kinase 1 ( SGK 1), and with‐no lysine kinase‐4 ( WNK 4). Renal sodium (Na + ) reabsorption and distal tubular membrane expression of NCC are reduced in mouse models of Fgf23 and α Klotho deficiency. Conversely, gain of FGF 23 function by injection of wild‐type mice with recombinant FGF 23 or by elevated circulating levels of endogenous Fgf23 in Hyp mice increases distal tubular Na + uptake and membrane abundance of NCC , leading to volume expansion, hypertension, and heart hypertrophy in a αKlotho and dietary Na + ‐dependent fashion. The NCC inhibitor chlorothiazide abrogates FGF 23‐induced volume expansion and heart hypertrophy. Our findings suggest that FGF 23 is a key regulator of renal Na + reabsorption and plasma volume, and may explain the association of FGF 23 with cardiovascular risk in chronic kidney disease patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · cited 2×
“Klotho is a single-pass transmembrane protein which is mainly expressed in the kidney in renal proximal and distal convoluted tubules, in parathyroid glands, but also in other tissues such as the brain choroid plexus (Kuro-o et al , 1997; Hu et al , 2010; Andrukhova et al , 2012).”
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027 · cited 2×
“…cardiovascular risk factors such as left ventricular hypertrophy, vascular calcifications, and mortality in CKD patients (Juppner et al , 2010; Faul et al , 2011), suggesting that FGF23 may have additional biological functions which cannot be explained by the known effects of FGF23 on mineral…”
FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S., & Yamashita, T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301264 · Cited by 1,883
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Human Hypertension Caused by Mutations in WNK Kinases
Wilson, F. H., Disse-Nicodème, S., Choate, K. A., Ishikawa, K., Nelson-Williams, C., Desitter, I., Gunel, M., Milford, D. V., Lipkin, G. W., Achard, J.-M., et al. (2001) · Science · doi:10.1126/science.1062844 · Cited by 1,487
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Dhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861 · cited 1×
“Hyperphosphatemia is a major risk factor for vascular calcification in patients with chronic renal disease (Scialla et al , 2013) and cardiovascular disease in normal subjects (Dhingra et al , 2007).”
Sgk1-Dependent Stimulation of Cardiac Na+/H+Exchanger Nhe1 by Dexamethasone
Voelkl, J., Pasham, V., Ahmed, M. S. E., Walker, B., Szteyn, K., Kuhl, D., Metzler, B., Alesutan, I., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350120 · Cited by 857
Epithelial sodium channel regulated by aldosterone-induced protein sgk
Chen, S.-Y., Bhargava, A., Mastroberardino, L., Meijer, O. C., Wang, J., Buse, P., Firestone, G. L., Verrey, F., & Pearce, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2514 · Cited by 734
Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney
Masilamani, S., Kim, G.-H., Mitchell, C., Wade, J. B., & Knepper, M. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7840 · Cited by 726
Georges, G. T., Nájera, O., Sowers, K., & Sowers, J. R. (2017) · Cardiorenal Medicine · doi:10.1159/000449476 · Cited by 680
Regulation and Function of the FGF23/Klotho Endocrine Pathways
Martin, A., David, V., & Quarles, L. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00002.2011 · Cited by 594
Lee, H. B., & Blaufox, M. D. (1985) · PubMed · Cited by 583
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
Hu, M. C., Shi, M., Zhang, J., Pastor, J., Nakatani, T., Lanske, B., Razzaque, M. S., Rosenblatt, K. P., Baum, M. G., Kuro‐O, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-154765 · Cited by 578
Self-citationSitara, D., Razzaque, M. S., Hesse, M., Yoganathan, S., Taguchi, T., Erben, R. G., J+APw-ppner, H., & Lanske, B. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.09.007 · Cited by 542
Self-citationLi, Y. C., Amling, M., Pirro, A. E., Priemel, M., Meuse, J., Baron, R., Delling, G., & Demay, M. B. (1998) · Endocrinology · doi:10.1210/endo.139.10.6262 · Cited by 524
Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
Liu, S., Guo, R., Simpson, L. G., Xiao, Z.-S., Burnham, C. E., & Quarles, L. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304544200 · Cited by 508
Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., & Nabeshima, Y.-I. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0048 · Cited by 491
Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo
Saito, H., Maeda, A., Ohtomo, S.-I., Hirata, M., Kusano, K., Kato, S., Ogata, E., Segawa, H., Miyamoto, K.-I., & Fukushima, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408903200 · Cited by 471
WNK kinases regulate thiazide-sensitive Na-Cl cotransport
Yang, C.-L., Angell, J., Mitchell, R., & Ellison, D. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17443 · Cited by 445
WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion
Kahle, K. T., Wilson, F. H., Leng, Q., Lalioti, M. D., O'Connell, A. D., Dong, K., Rapson, A. K., MacGregor, G. G., Giebisch, G., Hebert, S. C., et al. (2003) · Nature Genetics · doi:10.1038/ng1271 · Cited by 380
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
Shimada, T., Yamazaki, Y., Takahashi, M., Hasegawa, H., Urakawa, I., Oshima, T., Ono, K., Kakitani, M., Tomizuka, K., Fujita, T., et al. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00474.2004 · Cited by 360
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, O. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 354
Fluorescence ratio imaging of cytosolic free Na+ in individual fibroblasts and lymphocytes
Harootunian, A. T., Kao, J. P., Eckert, B. K., & Tsien, R. Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47322-5 · Cited by 336
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Scialla, J. J., Lau, W. L., Reilly, M. P., Isakova, T., Yang, H.-Y., Crouthamel, M. H., Chavkin, N. W., Rahman, M., Wahl, P., Amaral, A. P., et al. (2013) · Kidney International · doi:10.1038/ki.2013.3 · Cited by 333
Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
Xie, J., Cha, S.-K., An, S.-W., Kuro-o, M., Birnbaumer, L., & Huang, C.-L. (2012) · Nature Communications · doi:10.1038/ncomms2240 · Cited by 329
Erben, R. G., Soegiarto, D. W., Weber, K., Zeitz, U., Lieberherr, M., Gniadecki, R., Möller, G., Adamski, J., & Balling, R. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1524 · Cited by 290
Self-citationActivation of the renal Na + :Cl − cotransporter by angiotensin II is a WNK4-dependent process
Castañeda-Bueno, M., Cervantes-Pérez, L. G., Vázquez, N., Uribe, N., Kantesaria, S., Morla, L., Bobadilla, N. A., Doucet, A., Alessi, D. R., & Gamba, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200947109 · Cited by 264
Pacheco-Alvarez, D., Cristóbal, P. S., Meade, P., Moreno, E., Vazquez, N., Muñoz, E., Díaz, A., Juárez, M. E., Giménez, I., & Gamba, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603773200 · Cited by 243
Andrukhova, O., Zeitz, U., Goetz, R., Mohammadi, M., Lanske, B., & Erben, R. G. (2012) · Bone · doi:10.1016/j.bone.2012.05.015 · Cited by 226
Self-citationFGF23 promotes renal calcium reabsorption through the TRPV5 channel
Andrukhova, O., Smorodchenko, A., Egerbacher, M., Streicher, C., Zeitz, U., Goetz, R., Shalhoub, V., Mohammadi, M., Pohl, E. E., Lanske, B., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201284188 · Cited by 212
Self-citationHesse, M., Fröhlich, L. F., Zeitz, U., Lanske, B., & Erben, R. G. (2007) · Matrix Biology · doi:10.1016/j.matbio.2006.10.003 · Cited by 198
Self-citationMay, A., Puoti, A., Gaeggeler, H. P., Horisberger, J. D., & Rossier, B. C. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8121813 · Cited by 193
FGF-23: More than a regulator of renal phosphate handling?
Jüppner, H., Wolf, M. S., & Salusky, I. B. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.170 · Cited by 180
Ring, A. M., Leng, Q., Rinehart, J., Wilson, F. H., Kahle, K. T., Hebert, S. C., & Lifton, R. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611728104 · Cited by 164
Barros, N. M. T., Hoac, B., Neves, R. L., Addison, W. N., Assis, D. M., Murshed, M., Carmona, A. K., & McKee, M. D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1766 · Cited by 161
Rozansky, D. J., Cornwall, T., Subramanya, A. R., Rogers, S. L., Yang, Y.-F., David, L. L., Zhu, X., Yang, C., & Ellison, D. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38323 · Cited by 148
Bartter’s and Gitelman’s Syndromes: From Gene to Clinic
Naesens, M., Steels, P., Verberckmoes, R., et al. (2004) · Nephron Physiology · doi:10.1159/000076752 · Cited by 143
The physiological impact of the serum and glucocorticoid-inducible kinase SGK1
Lang, F., Artunc, F., & Vallon, V. (2009) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32832f125e · Cited by 139 · cited 1×
“SGK1 is a central molecule in the regulation of renal Na + handling and in the pathophysiology of hypertension and renal fibrosis (Lang et al , 2009).”
Cai, H., Cebotaru, V., Wang, Y.-H., Zhang, X. M., Cebotaru, L., Guggino, S. E., & Guggino, W. B. (2006) · Kidney International · doi:10.1038/sj.ki.5000333 · Cited by 134
Ohta, A., Rai, T., Yui, N., Chiga, M., Yang, S., Lin, S., Sohara, E., Sasaki, S., & Uchida, S. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp344 · Cited by 109
Nesterov, V., Dahlmann, A., Krueger, B., Bertog, M., Loffing, J., & Korbmacher, C. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00247.2012 · Cited by 106
Aldosterone does not require angiotensin II to activate NCC through a WNK4–SPAK–dependent pathway
van der Lubbe, N., Lim, C. H., Meima, M. E., et al. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1104-0 · Cited by 86
The role of Nedd4/Nedd4-like dependant ubiquitylation in epithelial transport processes
Flores, S. Y., Debonneville, C., & Staub, O. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1027-x · Cited by 79
Role of volume in the regulation of vasopressin secretion during pregnancy in the rat.
Barron, W. M., Stamoutsos, B. A., & Lindheimer, M. D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111316 · Cited by 78
Cardiovascular Abnormalities in Patients with X-Linked Hypophosphatemia
Nehgme, R., Fahey, J. T., Smith, C. R., & Carpenter, T. O. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4181 · Cited by 77
Hyperaldosteronism in Klotho-deficient mice
Fischer, S., Kempe, D. S., Leibrock, C. B., Rexhepaj, R., Siraskar, B. D., Boini, K. M., Ackermann, T. F., Föller, M., Hocher, B., Rosenblatt, K. P., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00233.2010 · Cited by 67
Sharma, S., McFann, K., Chonchol, M., de Boer, I. H., & Kendrick, J. (2013) · American Journal of Nephrology · doi:10.1159/000351178 · Cited by 64
Lee, I., Campbell, C. R., Song, S., Day, M. L., Kumar, S., Cook, D. I., & Dinudom, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809737200 · Cited by 59
RasGRP1 stimulation enhances ubiquitination and endocytosis of the sodium-chloride cotransporter
Ko, B. S., Kamsteeg, E., Cooke, L. L., Moddes, L., Deen, P. M. T., & Hoover, R. S. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00441.2009 · Cited by 59
Streicher, C., Zeitz, U., Andrukhova, O., Rupprecht, A., Pohl, E. E., Larsson, T. E., Windisch, W. M., Lanske, B., & Erben, R. G. (2012) · Endocrinology · doi:10.1210/en.2011-1878 · Cited by 58
Self-citationAldosterone acutely stimulates NCC activity via a SPAK-mediated pathway
Ko, B. S., Mistry, A. C., Hanson, L., Mallick, R., Wynne, B. M., Thai, T. L., Bailey, J. L., Klein, J. D., & Hoover, R. S. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00053.2013 · Cited by 58
Anour, R., Andrukhova, O., Ritter, E., Zeitz, U., & Erben, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031376 · Cited by 57
Self-citationLattanzio, M. R., & Weir, M. R. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0142-2 · Cited by 26
Cited by
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
The Klotho proteins in health and disease
Kuro-o, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0078-3 · Cited by 707
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 338
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Yamada, S., & Giachelli, C. M. (2017) · Bone · doi:10.1016/j.bone.2016.11.012 · Cited by 316
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Beck-Nielsen, S. S., Mughal, Z., Haffner, D., Nilsson, O., Levtchenko, E., Ariceta, G., de Lucas Collantes, C., Schnabel, D., Jandhyala, R., & Mäkitie, O. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1014-8 · Cited by 278
Metadata
- Authors
- Andrukhova, O., Slavic, S., Smorodchenko, A., Zeitz, U., Shalhoub, V., Lanske, B., Pohl, E. E., & Erben, R. G.
- Venue
- EMBO Molecular Medicine
- Published
- 2014-05-05
- Volume
- 6
- Issue
- 6
- Pages
- 744-759
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2167995070
- Cited by
- 320
- References
- 57
- FWCI
- 19.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.